- Home
- BB vs ATRC Comparison
BB vs ATRC Comparison
Compare BB & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BB
- ATRC
- Stock Information
- Founded
- BB 1984
- ATRC 2000
- Country
- BB Canada
- ATRC United States
- Employees
- BB N/A
- ATRC N/A
- Industry
- BB
- ATRC Medical/Dental Instruments
- Sector
- BB
- ATRC Health Care
- Exchange
- BB Nasdaq
- ATRC Nasdaq
- Market Cap
- BB 1.8B
- ATRC 1.5B
- IPO Year
- BB 1997
- ATRC 2005
- Fundamental
- Price
- BB $3.17
- ATRC $32.01
- Analyst Decision
- BB Buy
- ATRC Strong Buy
- Analyst Count
- BB 7
- ATRC 10
- Target Price
- BB $4.43
- ATRC $48.50
- AVG Volume (30 Days)
- BB 16.7M
- ATRC 556.9K
- Earning Date
- BB 04-02-2025
- ATRC 04-29-2025
- Dividend Yield
- BB N/A
- ATRC N/A
- EPS Growth
- BB N/A
- ATRC N/A
- EPS
- BB N/A
- ATRC N/A
- Revenue
- BB $534,900,000.00
- ATRC $465,307,000.00
- Revenue This Year
- BB $4.63
- ATRC $14.60
- Revenue Next Year
- BB $7.55
- ATRC $12.58
- P/E Ratio
- BB N/A
- ATRC N/A
- Revenue Growth
- BB N/A
- ATRC 16.55
- 52 Week Low
- BB $2.01
- ATRC $18.94
- 52 Week High
- BB $6.24
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- BB 34.98
- ATRC 43.87
- Support Level
- BB $3.13
- ATRC $29.48
- Resistance Level
- BB $3.33
- ATRC $33.56
- Average True Range (ATR)
- BB 0.24
- ATRC 2.13
- MACD
- BB 0.02
- ATRC 0.14
- Stochastic Oscillator
- BB 35.58
- ATRC 52.38
About BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communication for enterprises. The firm provides endpoint management and protection to enterprises, specializing in regulated industries like government, as well as embedded software to the automotive, medical, and industrial markets.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.